pharmaceutical investing Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo Phase 1 Combination Trial
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
RUA GOLD Reports Auld Creek Drilling Results Including 2.1m @ 64g/t AuEq Intersected 120m Below the Current Resource, Demonstrating Significant and Open-Ended Depth Potential
Hypromag Achieves Further Technical Milestones as Piloting Ramps Up in Advance of Commercial Rare Earth Magnet Production in The Uk, Germany and USA